5% stakes
TCG Crossover GP II
Institution
- 5% stake reports
- 26
- 5% stake stocks
- 18
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Alx Oncology Holdings ALXO08/14 | 4.2%5,655,487 sh | −5.7pp |
| First Tracks Biotherapeutics TRAX08/14 | 8.3%2,895,304 sh | First report |
| Fulcrum Therapeutics FULC08/14 | 0%0 sh | −7.9pp |
| LB Pharmaceuticals LBRX08/14 | 5%1,447,310 sh | −1.4pp |
| Tango Therapeutics TNGX08/14 | 7%10,147,867 sh | −1.1pp |
| Surrozen SRZN07/24 | 9.9%1,148,101 sh | −2.8pp |
| Zai Lab ZLAB06/11 | 5.3%59,130,750 sh | First report |
| LB Pharmaceuticals LBRX05/15 | 6.4%1,839,489 sh | −1.4pp |
| Surrozen SRZN05/15 | 12.7%1,473,101 sh | +1.3pp |
| Tango Therapeutics TNGX05/15 | 8.1%11,597,737 sh | −1.9pp |
| Monte Rosa Therapeutics GLUE05/15 | 5.5%4,622,151 sh | −1.7pp |
| Avalo Therapeutics AVTX05/12 | 7.9%3,017,120 sh | First report |
| Aura Biosciences AURA05/12 | 9.9%9,533,333 sh | First report |
| Altimmune ALT05/01 | 9.8%20,000,000 sh | First report |
| Vor Biopharma VOR04/01 | 10.5%5,673,078 sh | First report |
| Tectonic Therapeutic TECX02/27 | 6.2%1,169,760 sh | First report |
| ADC Therapeutics ADCT02/17 | 9.2%11,390,175 sh | First report |
| Tango Therapeutics TNGX02/17 | 9.99%13,521,839 sh | +3.7pp |
| Perspective Therapeutics CATX02/06 | 6.9%7,915,567 sh | First report |
| Alx Oncology Holdings ALXO02/06 | 9.9%13,011,849 sh | First report |
